Literature DB >> 3359683

Follow-up of 30 Klinefelter males treated with testosterone.

J Nielsen1, B Pelsen, K Sørensen.   

Abstract

Thirty Klinefelter males treated with testosterone were studied by a follow-up examination carried out an average of 3.6 years after treatment began. The age of the men averaged 25.5 years at the time of the follow-up. Seventy-seven per cent of the men were judged to have benefited from testosterone treatment. They showed better mood, less irritability, more energy and drive, less tiredness, more endurance and strength, less need for sleep, better concentration ability and better relations with others during testosterone treatment. The beneficial effects of testosterone persisted in some of the men after cessation of treatment. The findings show that Klinefelter males given testosterone for the first time as adults can benefit from such treatment, even though it is preferable to start treatment at the age of 11-12 years.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3359683     DOI: 10.1111/j.1399-0004.1988.tb03447.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  15 in total

1.  Assessing the risks and benefits of diagnosing genetic conditions with variable phenotypes through population screening: Klinefelter syndrome as an example.

Authors:  Amy Simone Herlihy; Jane Halliday; Rob I McLachlan; Megan Cock; Lynn Gillam
Journal:  J Community Genet       Date:  2010-03-29

Review 2.  Consensus statement on diagnosis and clinical management of Klinefelter syndrome.

Authors:  A F Radicioni; A Ferlin; G Balercia; D Pasquali; L Vignozzi; M Maggi; C Foresta; A Lenzi
Journal:  J Endocrinol Invest       Date:  2010-12       Impact factor: 4.256

Review 3.  Effects of the Timing of Sex-Steroid Exposure in Adolescence on Adult Health Outcomes.

Authors:  Yee-Ming Chan; Amalia Feld; Elfa Jonsdottir-Lewis
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

Review 4.  Risks versus benefits of testosterone therapy in elderly men.

Authors:  S Basaria; A S Dobs
Journal:  Drugs Aging       Date:  1999-08       Impact factor: 3.923

5.  Timing of diagnosis of 47,XXY and 48,XXYY: a survey of parent experiences.

Authors:  Jeannie Visootsak; Natalie Ayari; Susan Howell; Joash Lazarus; Nicole Tartaglia
Journal:  Am J Med Genet A       Date:  2013-01-15       Impact factor: 2.802

6.  Social function in multiple X and Y chromosome disorders: XXY, XYY, XXYY, XXXY.

Authors:  Jeannie Visootsak; John M Graham
Journal:  Dev Disabil Res Rev       Date:  2009

Review 7.  The cognitive phenotype in Klinefelter syndrome: a review of the literature including genetic and hormonal factors.

Authors:  Richard Boada; Jennifer Janusz; Christa Hutaff-Lee; Nicole Tartaglia
Journal:  Dev Disabil Res Rev       Date:  2009

Review 8.  Testis Development and Fertility Potential in Boys with Klinefelter Syndrome.

Authors:  Shanlee M Davis; Alan D Rogol; Judith L Ross
Journal:  Endocrinol Metab Clin North Am       Date:  2015-09-28       Impact factor: 4.741

Review 9.  Klinefelter syndrome and other sex chromosomal aneuploidies.

Authors:  Jeannie Visootsak; John M Graham
Journal:  Orphanet J Rare Dis       Date:  2006-10-24       Impact factor: 4.123

Review 10.  Sex differences in childhood sleep and health implications.

Authors:  Stacey D Elkhatib Smidt; Talia Hitt; Babette S Zemel; Jonathan A Mitchell
Journal:  Ann Hum Biol       Date:  2021-09       Impact factor: 1.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.